Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 17, 2015 |
| Target | T-Cell Factory B.V. |
| Sector | Life Science |
| Buyer(s) | Kite Pharma |
| Deal Type | Add-on Acquisition |
| Deal Value | 20M EUR |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2009 |
| Sector | Life Science |
| Employees | 184 |
| Revenue | 22M USD (2016) |
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Life Science | 1 of 4 |
| Type: Add-on Acquisition | 1 of 3 |
| Country: Netherlands | 1 of 1 |
| Year: 2015 | 1 of 1 |
| Size (of disclosed) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-07 |
Cell Design Labs
Emeryville, California, United States Cell Design Labs, Inc. is a biotherapeutics company pioneering breakthrough science to develop disruptive therapies for cancer and other devastating diseases. Cell Design Labs, Inc. was founded in 2015 and is based in San Emeryville, California. |
Buy | $567M |
